ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Working Group Beings AID-Related Lymphoma research

October 19, 1990

NCI Payline For Fiscal 1986 To Be 160 or 165

October 11, 1985

ORI Finds Researcher Falsified Records

February 9, 1996

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981